6 results
ACR Guidelines for Vaccines in Patients with Rheumatic & Musculoskeletal Diseases 2022

Vaccine Guidance:
 • Expanded Indications
ACR Guidelines for ... : • Expanded Indications ... #vaccination #Guidelines ... #rheumatology # ... management #immunocompromised
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... • Giant Cell Arteritis ... • Takayasu's arteritis ... (TAK) • Polyarteritis ... #algorithm #rheumatology
2021 ACR/VF Guidelines for Management of Takayasu Arteritis (TAK)

#Takayasu #Arteritis #TAK #ACR2021 #Management #rheumatology #algorithm #vasculitis
2021 ACR/VF Guidelines ... for Management ... (TAK) #Takayasu ... #Arteritis #TAK ... #rheumatology #
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Takayasus #Arteritis ... #algorithm #rheumatology
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
JAK Inhibitors in ... , Psoriatic Arthritis ... JAKInhibitors #Indications ... #Rheumatology # ... Management
2021 ACR Guidance for Adjusting Immunomodulatory Therapy related to the COVID-19 Vaccine in Patients with Rheumatic
Cyclophosphamide, JAK ... MithuRheum #ACR2021 #Guidelines ... #COVID19 #management ... #rheumatology # ... vaccine